“Future-fit.”
“Engagement excellence.”
These buzzwords dominate the pharma conversation. But what do they actually look like in practice? Our report dives beneath the jargon to expose the real changes underway in HCP engagement and capability development.
If your role touches commercialization strategy, learning & development or HCP engagement, this report will challenge your thinking and guide your next move.
We partnered with over 70 commercial, medical, and market access leaders from 20 top pharmaceutical companies – spanning the US, UK, EU, Africa, and APAC – to uncover what’s next for field and remote teams.
Conducted between August – October 2024 by Nazaré’s capability development experts in HCP engagement, this research combines deep-dive interviews and quantitative insights.
Whether you lead a Field Team, oversee training programs, or shape commercial strategies, this report gives you the insight to:
Get ahead of the curve.
Jump to a slide with the slide dots.
ATTR-CM may be described as rare, but many patients are simply going undiagnosed. Delayed recognition, fragmented care, and limited access continue...
Read more
Inizio Engage XD appoints Colin Melville as Executive Creative Director to lead AI-driven creativity, immersive experiences, and innovation globally.
Read more
Discover insights into life sciences recruitment in the Nordics, market access, and regulatory talent from Inizio Engage’s Sidsel Tenold.
Read more
Colin Melville has been recognized in PM360’s ELITE 100 Awards for disrupting healthcare storytelling through generative AI and creative innovation.
Read more
Discover how Pipeline Medical Science Liaisons improve clinical trial recruitment, site engagement, and operational efficiency across development..
Read more